May 2017

Findings with the P140 peptide support a direct cross-talk between autophagy and certain central and peripheral neuronal diseases

Download

November 2016

Cancer compound IPP-204106 chosen to be on the cover of AACR disclosing the specific binding to nucleolin and therefore to tumour cells by the Nucants.

 

Download

March 2015

Special article “Resetting the autoreactive immune system with a therapeutic peptide in lupus” on autophagy

Download

October 2013

New Opportunities for Therapy of Autoimmune Diseases: published in Genetics & Epigenetics outlinung the potential in other indications

Download

November 2012

Publication of Lupuzor’s double blind phase IIb results in the Annals of the Rheumatic Diseases of the British Medical Journal

Download

September 2012

Publication in the Journal of Autoimmunity on Peptide-based approaches to treat lupus and other autoimmune diseases

Download

May 2011

How ImmuPharma’s IPP-204106 works in cancer treatment

Web Link

December 2010

Annals of the Rheumatic Diseases paper on mode of action of Lupuzor on HSC70+ antigen-presenting cells

Download

April 2009

Publication in PLoS One – Lupuzor (P140) controls Lupus by interacting with the HSC70 protein and via a mechanism mediated by γδ T cells

Download

December 2008

Results of an early phase II clinical trial of Lupuzor published in ARTHRITIS & RHEUMATISM of the American College of Rheumatology

Download